España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
icad
ICAD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.70
-0.13
-4.59%
At close: -
$2.66
-0.04
-1.48%
After Hours: 4:11 PM EDT
Get Report
Comment
icad (ICAD) Forecast
News
Earnings
icad (ICAD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for icad (NASDAQ:ICAD) Stock
icad Stock (NASDAQ: ICAD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, February 03, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Monday, January 27, 2025
Icad shares are trading higher after the comp...
Benzinga Newsdesk
ICAD Expects Q4 2024 Revenue Between $5.1M-$5...
Benzinga Newsdesk
Tuesday, November 26, 2024
iCAD shares are trading higher after the comp...
Benzinga Newsdesk
iCAD Presents Next-Generation AI Solutions An...
Benzinga Newsdesk
Thursday, November 14, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Icad shares are trading lower after the compa...
Benzinga Newsdesk
Wednesday, November 13, 2024
Icad shares are trading lower after the compa...
Benzinga Newsdesk
icad Q3 2024 Adj. EPS $(0.07) Beats $(0.08) E...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, November 12, 2024
Earnings Outlook For icad
Benzinga Insights
Monday, November 11, 2024
iCAD Announces The FDA 510k Review Panel Has ...
Benzinga Newsdesk
Wednesday, August 14, 2024
Icad shares are trading higher after the comp...
Benzinga Newsdesk
Tuesday, August 13, 2024
icad Q2 2024 GAAP EPS $(0.07), Inline, Sales ...
Benzinga Newsdesk
Monday, July 29, 2024
iCAD And Windsong Radiology Ink Strategic Com...
Benzinga Newsdesk
Wednesday, June 26, 2024
iCAD to Highlight Research On Potential Of It...
Benzinga Newsdesk
Monday, May 27, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Wednesday, May 15, 2024
icad Q1 Adj $(0.05) Beats $(0.06) Estimate, S...
Benzinga Newsdesk
Tuesday, April 09, 2024
iCAD And Densitas Partner To Enhance Precisio...
Benzinga Newsdesk
Monday, April 08, 2024
iCAD's ProFound AI Suite Uncovers Hidden Hear...
Benzinga Newsdesk
Wednesday, April 03, 2024
iCad shares are trading higher after the comp...
Benzinga Newsdesk
iCAD Partners With RAD-AID To Advance Breast ...
Benzinga Newsdesk
Tuesday, March 12, 2024
icad: Q4 Earnings Insights
Benzinga Insights
icad Q4 2023 Adj EPS $(0.02) Beats $(0.05) Es...
Benzinga Newsdesk
Earnings Scheduled For March 12, 2024
Benzinga Insights
Monday, March 11, 2024
Earnings Outlook For icad
Benzinga Insights
Wednesday, February 28, 2024
iCAD shares are trading higher after the comp...
Benzinga Newsdesk
iCAD Highlights Clinical Data Demonstrating A...
Benzinga Newsdesk
Tuesday, November 28, 2023
iCAD shares are trading higher after the comp...
Benzinga Newsdesk
iCAD Announces Apps From The iCAD Breast Heal...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, November 27, 2023
iCAD's ProFound AI Can Predict 1-2 Year Risk ...
Benzinga Newsdesk
Monday, November 20, 2023
iCAD And CancerIQ Have Announced A New Partne...
Benzinga Newsdesk
Monday, November 13, 2023
Recap: icad Q3 Earnings
Benzinga Insights
icad Q3 2023 Gaap EPS $(0.05) Beats $(0.08) E...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights
Friday, November 10, 2023
Earnings Outlook For icad
Benzinga Insights
Thursday, November 02, 2023
icad Director Awarded $44K Worth of Stock Options
Benzinga Insights
Monday, October 23, 2023
iCAD, Inc. Announces Sale Of Xoft Brachythera...
Benzinga Newsdesk
Wednesday, August 16, 2023
iCAD Announced Health Canada Has Issued A Dev...
Benzinga Newsdesk
Monday, August 14, 2023
icad Q2 Adj $(0.07) Up From $(0.12) YoY, Sale...
Benzinga Newsdesk
iCAD And Google Health Expand Integration of Google's AI Technology With iCAD's ProFound Breast Health Suite For 2D Mammography For Use As Independent Reader
Happy Mohamed
Earnings Scheduled For August 14, 2023
Benzinga Insights
Wednesday, August 09, 2023
Board Member at icad Acquires Company Stock Options Worth 13,137 Shares
Benzinga Insights
Director at icad Acquires Company Stock Options Worth 11,361 Shares
Benzinga Insights
Director at icad Acquires Company Stock Options Worth 12,954 Shares
Benzinga Insights
Thursday, July 27, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, July 26, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Wednesday, July 19, 2023
Lake Street Maintains Buy on icad, Raises Pri...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
